Cover Image
Market Research Report
Product code 
1029688

North America Lactoferrin Market By Function, By Application, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

Published: | KBV Research | 73 Pages | Delivery time: 1-2 business days

Price

Back to Top
North America Lactoferrin Market By Function, By Application, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027
Published: August 31, 2021
KBV Research
Content info: 73 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The North America Lactoferrin Market would witness market growth of 8.26% CAGR during the forecast period (2021-2027).

Lactoferrin refers to a protein supplement that is available in milk. It is utilized as medicine for the treatment of various diseases such as hepatitis C, stomach & intestinal ulcers, and diarrhea. It also plays the role of antioxidant against viral and bacterial infections. It offers various advantages for the body that involves preventing tissue damage, activating the immune system, reducing the possibility of cancer, and other advantages that are beneficial for the overall growth of the body. It is completely safe to consume in food; though, its high consumption can cause some side effects. It is highly available across online as well as offline retail channels. Moreover, it is majorly available in the form of powder.

North America is home to some of the key market players, hence is a leading region of the global lactoferrin market. In addition, the high availability of lactoferrin across different supermarkets and hypermarkets in this region would propel the adoption of the products. The key market players are adopting various strategies such as branding & marketing initiatives that have boosted the popularity of their items using informative leaflets and circulars, hence accelerating the demand for lactoferrin in the regional market.

Makers are aiming to understand the constantly changing consumer purchasing behavior in order to cater to the ever-changing demands. Companies are increasingly putting hefty investment in packaging and improvements of ingredients based on the fact that if the point-of-purchase is a specialty store, online shopping portal, or club warehouse. Consumers prefer organic products that have fewer carbon footprints. Various research and experiments further bolster the advantages provided by lactoferrin in several applications that would fuel its demand over the upcoming years.

Lactoferrin has anti-inflammatory effects that may be effective in the pathophysiology of cases regarding COVID-19. The demand for immunity boosters is propelled by the unavailability of a vaccine or cure for the novel coronavirus in 2020. Preventive steps for the COVID-19 infection have achieved massive traction around the globe, leading to higher demand for products based on lactoferrin in 2020.

The USA market dominated the North America Immune cell stimulation Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $10,736 Thousands by 2027. The Canada market is experiencing a CAGR of 8.9% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 11.1% during (2021 - 2027).

Based on Function, the market is segmented into Iron absorption, Intestinal flora protection, Immune cell stimulation, Antioxidant, Antibacterial and Anti-inflammatory. Based on Application, the market is segmented into Pharmaceuticals, Food & Beverages, Personal Care Products, Infant Formula, Sports & Functional Foods and Animal Feed. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Royal FrieslandCampina N.V., Glanbia PLC, Fonterra Co-operative Group Limited, Moringa Milk Industry Co., Ltd., Ventria Bioscience, Inc. (InVitria), Farbest Brands, Bega Cheese Ltd (Tatura Milk Industries Ltd.), MP Biomedicals LLC (Valiant Co., Ltd.), Synlait Milk Limited, and Pharming Group NV.

Scope of the Study

Market Segments covered in the Report:

By Function

  • Iron absorption
  • Intestinal flora protection
  • Immune cell stimulation
  • Antioxidant
  • Antibacterial
  • Anti-inflammatory

By Application

  • Pharmaceuticals
  • Food & Beverages
  • Personal Care Products
  • Infant Formula
  • Sports & Functional Foods
  • Animal Feed

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Royal FrieslandCampina N.V.
  • Glanbia PLC
  • Fonterra Co-operative Group Limited
  • Moringa Milk Industry Co., Ltd.
  • Ventria Bioscience, Inc. (InVitria)
  • Farbest Brands
  • Bega Cheese Ltd (Tatura Milk Industries Ltd.)
  • MP Biomedicals LLC (Valiant Co., Ltd.)
  • Synlait Milk Limited
  • Pharming Group NV

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1. Market Definition
  • 1.2. Objectives
  • 1.3. Market Scope
  • 1.4. Segmentation
    • 1.4.1. North America Lactoferrin Market, by Function
    • 1.4.2. North America Lactoferrin Market, by Application
    • 1.4.3. North America Lactoferrin Market, by Country
  • 1.5. Methodology for the research

Chapter 2. Market Overview

  • 2.1. Introduction
    • 2.1.1. Overview
      • 2.1.1.1. COVID-19 Impact
      • 2.1.1.2. Market Composition and Scenario
  • 2.2. Key Factors Impacting the Market
    • 2.2.1. Market Drivers
    • 2.2.2. Market Restraints

Chapter 3. North America Lactoferrin Market by Function

  • 3.1. North America Iron absorption Market by Country
  • 3.2. North America Intestinal flora protection Market by Country
  • 3.3. North America Immune cell stimulation Market by Country
  • 3.4. North America Antioxidant Market by Country
  • 3.5. North America Antibacterial Market by Country
  • 3.6. North America Anti-inflammatory Market by Country

Chapter 4. North America Lactoferrin Market by Application

  • 4.1. North America Pharmaceuticals Market by Country
  • 4.2. North America Food & Beverages Market by Country
  • 4.3. North America Personal Care Products Market by Country
  • 4.4. North America Infant Formula Market by Country
  • 4.5. North America Sports & Functional Foods Market by Country
  • 4.6. North America Animal Feed Market by Country

Chapter 5. North America Lactoferrin Market by Country

  • 5.1. USA Lactoferrin Market
    • 5.1.1. USA Lactoferrin Market by Function
    • 5.1.2. USA Lactoferrin Market by Application
  • 5.2. Canada Lactoferrin Market
    • 5.2.1. Canada Lactoferrin Market by Function
    • 5.2.2. Canada Lactoferrin Market by Application
  • 5.3. Mexico Lactoferrin Market
    • 5.3.1. Mexico Lactoferrin Market by Function
    • 5.3.2. Mexico Lactoferrin Market by Application
  • 5.4. Rest of North America Lactoferrin Market
    • 5.4.1. Rest of North America Lactoferrin Market by Function
    • 5.4.2. Rest of North America Lactoferrin Market by Application

Chapter 6. Company Profiles

  • 6.1. Royal FrieslandCampina N.V.
    • 6.1.1. Company Overview
    • 6.1.1. Financial Analysis
    • 6.1.2. Segmental and Regional Analysis
    • 6.1.3. Research & Development Expense
    • 6.1.4. Recent strategies and developments:
      • 6.1.4.1. Partnerships, Collaborations, and Agreements:
      • 6.1.4.2. Product Launches and Product Expansions:
  • 6.2. Glanbia PLC
    • 6.2.1. Company Overview
    • 6.2.2. Financial Analysis
    • 6.2.3. Segmental and Regional Analysis
    • 6.2.4. Research & Development Expense
    • 6.3.3. Segmental and Regional Analysis
  • 6.4. Moringa Milk Industry Co., Ltd.
    • 6.4.1. Company Overview
    • 6.4.2. Financial Analysis
    • 6.4.3. Segmental Analysis
    • 6.4.4. Research & Development Expenses
    • 6.4.5. Recent strategies and developments:
      • 6.4.5.1. Partnerships, Collaborations, and Agreements:
      • 6.4.5.2. Geographical Expansions:
  • 6.5. Ventria Bioscience, Inc. (InVitria)
    • 6.5.1. Company Overview
  • 6.6. Farbest Brands
    • 6.6.1. Company Overview
  • 6.7. Bega Cheese Ltd (Tatura Milk Industries Ltd.)
    • 6.7.1. Company Overview
    • 6.7.2. Financial Analysis
    • 6.7.3. Segmental and Regional Analysis
    • 6.7.4. Recent strategies and developments:
      • 6.7.4.1. Product Launches and Product Expansions:
      • 6.7.4.2. Geographical Expansions:
  • 6.8. MP Biomedicals LLC (Valiant Co., Ltd.)
    • 6.8.1. Company Overview
  • 6.9. Synlait Milk Limited
    • 6.9.1. Company Overview
    • 6.9.2. Financial Analysis
    • 6.9.3. Regional Analysis
    • 6.9.4. Recent strategies and developments:
      • 6.9.4.1. Partnerships, Collaborations, and Agreements:
      • 6.9.4.2. Geographical Expansions:
  • 6.10. Pharming Group NV
    • 6.10.1. Company Overview
    • 6.10.2. Financial Analysis
    • 6.10.3. Regional Analysis
    • 6.10.4. Research & Development Expenses

LIST OF TABLES

  • TABLE 1: NORTH AMERICA LACTOFERRIN MARKET, 2017 - 2020, USD THOUSANDS
  • TABLE 2: NORTH AMERICA LACTOFERRIN MARKET, 2021 - 2027, USD THOUSANDS
  • TABLE 3: NORTH AMERICA LACTOFERRIN MARKET BY FUNCTION, 2017 - 2020, USD THOUSANDS
  • TABLE 4: NORTH AMERICA LACTOFERRIN MARKET BY FUNCTION, 2021 - 2027, USD THOUSANDS
  • TABLE 5: NORTH AMERICA IRON ABSORPTION MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 6: NORTH AMERICA IRON ABSORPTION MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 7: NORTH AMERICA INTESTINAL FLORA PROTECTION MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 8: NORTH AMERICA INTESTINAL FLORA PROTECTION MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 9: NORTH AMERICA IMMUNE CELL STIMULATION MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 10: NORTH AMERICA IMMUNE CELL STIMULATION MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 11: NORTH AMERICA ANTIOXIDANT MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 12: NORTH AMERICA ANTIOXIDANT MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 13: NORTH AMERICA ANTIBACTERIAL MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 14: NORTH AMERICA ANTIBACTERIAL MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 15: NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 16: NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 17: NORTH AMERICA LACTOFERRIN MARKET BY APPLICATION, 2017 - 2020, USD THOUSANDS
  • TABLE 18: NORTH AMERICA LACTOFERRIN MARKET BY APPLICATION, 2021 - 2027, USD THOUSANDS
  • TABLE 19: NORTH AMERICA PHARMACEUTICALS MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 20: NORTH AMERICA PHARMACEUTICALS MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 21: NORTH AMERICA FOOD & BEVERAGES MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 22: NORTH AMERICA FOOD & BEVERAGES MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 23: NORTH AMERICA PERSONAL CARE PRODUCTS MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 24: NORTH AMERICA PERSONAL CARE PRODUCTS MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 25: NORTH AMERICA INFANT FORMULA MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 26: NORTH AMERICA INFANT FORMULA MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 27: NORTH AMERICA SPORTS & FUNCTIONAL FOODS MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 28: NORTH AMERICA SPORTS & FUNCTIONAL FOODS MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 29: NORTH AMERICA ANIMAL FEED MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 30: NORTH AMERICA ANIMAL FEED MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 31: NORTH AMERICA LACTOFERRIN MARKET BY COUNTRY, 2017 - 2020, USD THOUSANDS
  • TABLE 32: NORTH AMERICA LACTOFERRIN MARKET BY COUNTRY, 2021 - 2027, USD THOUSANDS
  • TABLE 33: USA LACTOFERRIN MARKET, 2017 - 2020, USD THOUSANDS
  • TABLE 34: USA LACTOFERRIN MARKET, 2021 - 2027, USD THOUSANDS
  • TABLE 35: USA LACTOFERRIN MARKET BY FUNCTION, 2017 - 2020, USD THOUSANDS
  • TABLE 36: USA LACTOFERRIN MARKET BY FUNCTION, 2021 - 2027, USD THOUSANDS
  • TABLE 37: USA LACTOFERRIN MARKET BY APPLICATION, 2017 - 2020, USD THOUSANDS
  • TABLE 38: USA LACTOFERRIN MARKET BY APPLICATION, 2021 - 2027, USD THOUSANDS
  • TABLE 39: CANADA LACTOFERRIN MARKET, 2017 - 2020, USD THOUSANDS
  • TABLE 40: CANADA LACTOFERRIN MARKET, 2021 - 2027, USD THOUSANDS
  • TABLE 41: CANADA LACTOFERRIN MARKET BY FUNCTION, 2017 - 2020, USD THOUSANDS
  • TABLE 42: CANADA LACTOFERRIN MARKET BY FUNCTION, 2021 - 2027, USD THOUSANDS
  • TABLE 43: CANADA LACTOFERRIN MARKET BY APPLICATION, 2017 - 2020, USD THOUSANDS
  • TABLE 44: CANADA LACTOFERRIN MARKET BY APPLICATION, 2021 - 2027, USD THOUSANDS
  • TABLE 45: MEXICO LACTOFERRIN MARKET, 2017 - 2020, USD THOUSANDS
  • TABLE 46: MEXICO LACTOFERRIN MARKET, 2021 - 2027, USD THOUSANDS
  • TABLE 47: MEXICO LACTOFERRIN MARKET BY FUNCTION, 2017 - 2020, USD THOUSANDS
  • TABLE 48: MEXICO LACTOFERRIN MARKET BY FUNCTION, 2021 - 2027, USD THOUSANDS
  • TABLE 49: MEXICO LACTOFERRIN MARKET BY APPLICATION, 2017 - 2020, USD THOUSANDS
  • TABLE 50: MEXICO LACTOFERRIN MARKET BY APPLICATION, 2021 - 2027, USD THOUSANDS
  • TABLE 51: REST OF NORTH AMERICA LACTOFERRIN MARKET, 2017 - 2020, USD THOUSANDS
  • TABLE 52: REST OF NORTH AMERICA LACTOFERRIN MARKET, 2021 - 2027, USD THOUSANDS
  • TABLE 53: REST OF NORTH AMERICA LACTOFERRIN MARKET BY FUNCTION, 2017 - 2020, USD THOUSANDS
  • TABLE 54: REST OF NORTH AMERICA LACTOFERRIN MARKET BY FUNCTION, 2021 - 2027, USD THOUSANDS
  • TABLE 55: REST OF NORTH AMERICA LACTOFERRIN MARKET BY APPLICATION, 2017 - 2020, USD THOUSANDS
  • TABLE 56: REST OF NORTH AMERICA LACTOFERRIN MARKET BY APPLICATION, 2021 - 2027, USD THOUSANDS
  • TABLE 57: KEY INFORMATION - ROYAL FRIESLANDCAMPINA N.V.
  • TABLE 58: KEY INFORMATION - GLANBIA PLC
  • TABLE 60: KEY INFORMATION - MORINAGA MILK INDUSTRY CO., LTD.
  • TABLE 61: KEY INFORMATION - VENTRIA BIOSCIENCE INC.
  • TABLE 62: KEY INFORMATION - FARBEST BRANDS
  • TABLE 63: KEY INFORMATION - BEGA CHEESE LTD.
  • TABLE 64: KEY INFORMATION - MP BIOMEDICALS LLC
  • TABLE 65: KEY INFORMATION - SYNLAIT MILK LIMITED
  • TABLE 66: KEY INFORMATION - PHARMING GROUP NV

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH
  • FIG 2: RECENT STRATEGIES AND DEVELOPMENTS: ROYAL FRIESLANDCAMPINA N.V.
  • FIG 3: RECENT STRATEGIES AND DEVELOPMENTS: MORINAGA MILK INDUSTRY CO., LTD.
  • FIG 4: RECENT STRATEGIES AND DEVELOPMENTS: BEGA CHEESE LTD.
  • FIG 5: RECENT STRATEGIES AND DEVELOPMENTS: SYNLAIT MILK LIMITED